Reuters logo
BRIEF-Mylan reports Q3 adjusted earnings per share $1.10
2017年11月6日 / 中午12点28分 / 15 天前

BRIEF-Mylan reports Q3 adjusted earnings per share $1.10

Nov 6 (Reuters) - Mylan Nv

* Mylan reports third quarter 2017 results and updates 2017 guidance

* Sees FY 2017 adjusted earnings per share $4.45 to $4.70

* Q3 adjusted earnings per share $1.10

* Sees FY 2017 revenue $11.75 billion to $12.5 billion

* Q3 revenue $2.99 billion versus I/B/E/S view $3.09 billion

* Q3 earnings per share view $1.20 -- Thomson Reuters I/B/E/S

* Mylan NV - Qtrly ‍U.S. GAAP diluted earnings per ordinary share of $0.16​

* Mylan - Primarily due to launch of generic Copaxone, co is increasing midpoint of 2017 adjusted EPS guidance & total revenue range by increasing low end of ranges

* Mylan NV - ‍​Sales of EpiPen auto-injector in North America segment declined in current quarter by $245.1 million

* Mylan- EpiPen auto-injector sales in North America fell in current quarter from higher governmental rebates from $465 million settlement with U.S. DoJ, among others

* Mylan NV says ‍​“remain confident” in 2018 target of at least $5.40 in adjusted EPS Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below